FDA Approved: VYVGART — Original Application (argenx US)

View source ↗

Summary

The FDA approved VYVGART (efgartigimod alfa) in its original application for the treatment of generalized myasthenia gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• VYVGART (EFGARTIGIMOD ALFA)

Snippet

ORIG AP for VYVGART (EFGARTIGIMOD ALFA)